Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ava Sadi"'
Autor:
Lucy Rutten, Maarten Swart, Annemart Koornneef, Pascale Bouchier, Sven Blokland, Ava Sadi, Jarek Juraszek, Aneesh Vijayan, Sonja Schmit-Tillemans, Johan Verspuij, Ying Choi, Chenandly E. Daal, Aditya Perkasa, Shessy Torres Morales, Sebenzile K. Myeni, Marjolein Kikkert, Jeroen Tolboom, Daniëlle van Manen, Harmjan Kuipers, Hanneke Schuitemaker, Roland Zahn, Johannes P. M. Langedijk
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract The spike protein (S) of SARS-CoV-2 induces neutralizing antibodies and is the key component of current COVID-19 vaccines. The most efficacious COVID-19 vaccines are genetically-encoded spikes with a double proline substitution in the hinge
Externí odkaz:
https://doaj.org/article/2c5d3e1e3a7e47e1962a95fc294bb57c
Publikováno v:
Cornea. 36:961-966
PURPOSE To identify preoperative and intraoperative factors affecting breakthrough corneal haze incidence after photorefractive keratectomy (PRK) with mitomycin C (MMC). METHODS In this retrospective study of PRK performed at the Care Vision Refracti
Autor:
Christophe Blanchetot, Michael A. Saunders, Paolo Michieli, Virginia Morello, Valérie Hanssens, Mohamed El Khattabi, Anna Hultberg, Marie Godar, Cristina Basilico, Hans de Haard, Natalie De Jonge, Ava Sadi, Bart N. Lambrecht
Publikováno v:
Scientific Reports
Scientific Reports, 6:31621. Nature Publishing Group
SCIENTIFIC REPORTS
Scientific Reports, 6:31621. Nature Publishing Group
SCIENTIFIC REPORTS
Bispecific antibodies are of great interest due to their ability to simultaneously bind and engage different antigens or epitopes. Nevertheless, it remains a challenge to assemble, produce and/or purify them. Here we present an innovative dual anti-i
Autor:
Christian Cambillau, Alex Klarenbeek, Nico Ongenae, Anke Kretz-Rommel, Ava Sadi, Remy Loris, Hans de Haard, Natalie De Jonge, Silvia Spinelli, Anna Hultberg, Erik G. Hofman, Christophe Blanchetot, Aline Desmyter
Publikováno v:
Journal of Biological Chemistry
Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2016, 291 (26), pp.13846-13854. ⟨10.1074/jbc.M115.695528⟩
'Journal of Biological Chemistry ', vol: 291, pages: 13846-13854 (2016)
Journal of Biological Chemistry, 2016, 291 (26), pp.13846-13854. ⟨10.1074/jbc.M115.695528⟩
The Journal of Biological Chemistry
Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2016, 291 (26), pp.13846-13854. ⟨10.1074/jbc.M115.695528⟩
'Journal of Biological Chemistry ', vol: 291, pages: 13846-13854 (2016)
Journal of Biological Chemistry, 2016, 291 (26), pp.13846-13854. ⟨10.1074/jbc.M115.695528⟩
The Journal of Biological Chemistry
Interleukin 6 plays a key role in mediating inflammatory reactions in autoimmune diseases and cancer, where it is also involved in metastasis and tissue invasion. Neutralizing antibodies against IL-6 and its receptor have been approved for therapeuti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f10344b4a46e0360f825d380c857a93b
https://hal.archives-ouvertes.fr/hal-01439109
https://hal.archives-ouvertes.fr/hal-01439109
Autor:
Nico Ongenae, Anna Hultberg, Christian Cambillau, Christophe Blanchetot, Torsten Dreier, Silvia Spinelli, Wieger Hemrika, John Wijdenes, Ava Sadi, Rob C. Roovers, Alex Klarenbeek, Anke Kretz-Rommel, Hans de Haard, Georg Schragel, Aline Desmyter
Publikováno v:
Protein Engineering, Design and Selection
Protein Engineering, Design and Selection, Oxford University Press (OUP), 2016, 29 (4), pp.123-133. ⟨10.1093/protein/gzw003⟩
Protein Engineering, Design and Selection, 2016, 29 (4), pp.123-133. ⟨10.1093/protein/gzw003⟩
Protein Engineering, Design and Selection, Oxford University Press (OUP), 2016, 29 (4), pp.123-133. ⟨10.1093/protein/gzw003⟩
Protein Engineering, Design and Selection, 2016, 29 (4), pp.123-133. ⟨10.1093/protein/gzw003⟩
Highly potent human antibodies are required to therapeutically neutralize cytokines such as interleukin-6 (IL-6) that is involved in many inflammatory diseases and malignancies. Although a number of mutagenesis approaches exist to perform antibody af
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c49a6a706c7c5b3a85e8c888687bc7cd
https://hal.archives-ouvertes.fr/hal-01439062
https://hal.archives-ouvertes.fr/hal-01439062